Showing results (171-180 of 289) with videos related to

Sort By:
Pageof 29
The Journal of Antimicrobial Chemotherapy|October 18, 2017
VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicansTimothy J Break, Jigar V Desai, Mukil Natarajan, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Candidozyma auris utilizes transferrin, but not heme-bound iron for in vivo virulenceTanmay Arekar, Divya Katikaneni, Thrisha Acharya, et al.
The Journal of Allergy and Clinical Immunology|March 26, 2025
Update on the genetics of allergic diseasesLucinda P Lawson, Sreeja Parameswaran, Ronald A Panganiban, et al.
Journal of Clinical Immunology|November 18, 2021
CARD9 Expression Pattern, Gene Dosage, and Immunodeficiency Phenotype RevisitedShubham Goel, Hye Sun Kuehn, Javier Chinen, et al.
Human Molecular Genetics|April 5, 2018
Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic interventionAntony Cougnoux, Rebecca A Drummond, Amanda L Collar, et al.
The Journal of Infection|August 14, 2025
Neutralizing GM-CSF autoantibodies impair neutrophil antifungal effector function in a patient with aspergillosisAndrew L Wishart, Joseph Pechacek, Lindsey B Rosen, et al.
Journal of Rehabilitation Research and Development|February 17, 2010
Age-associated striatal dopaminergic denervation and falls in community-dwelling subjectsNicolaas I Bohnen, Martijn L T M Muller, Hiroto Kuwabara, et al.
Open Forum Infectious Diseases|August 2, 2024
Successful Treatment of Refractory Cutaneous Protothecosis With MAT2203, an Oral Lipid Nanocrystal Formulation of Amphotericin BJoseph Pechacek, Monica M Schmitt, Elise M N Ferrè, et al.
Journal of Neuroinflammation|December 30, 2019
Unique molecular signature in mucolipidosis type IV microgliaAntony Cougnoux, Rebecca A Drummond, Mason Fellmeth, et al.
Pageof 29